Shulman De Meo Asset Management LLC Bristol Myers Squibb CO Transaction History

Shulman De Meo Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 27, 2022	SELL	$61.48 - $73.72 $207,986 - $249,394	-3,383 Closed	0 $0
Q4 2021 Jan 28, 2022	BUY	$53.63 - $62.52 $181,430 - $211,505	3,383 New	3,383 $211,000
Q4 2019 Jan 15, 2020	SELL	$49.21 - $64.19 $241,670 - $315,237	-4,911 Closed	0 $0
Q3 2019 Oct 30, 2019	SELL	$42.77 - $50.71 $35,541 - $42,140	-831 Reduced 14.47%	4,911 $249,000
Q2 2019 Jul 18, 2019	SELL	$44.62 - $49.34 $3,257 - $3,601	-73 Reduced 1.26%	5,742 $260,000

Q1 2019 May 01, 2019	BUY	$45.12 - $53.8 $262,372 - $312,847	5,815 New	5,815 $277,000

2,553

1.49B

25.9M

20M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $84.3B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Shulman De Meo Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Shulman De Meo Asset Management LLC with notifications on news.